Bio-Rad Laboratories, a global provider of life science research and clinical diagnostics products, has launched a newly enhanced version of its Liquichek Diabetes Control, part of the company’s family of controls designed to monitor the precision of hemoglobin testing associated with diabetes monitoring.
The Liquichek Diabetes Control comes in three distinct levels to address the HbA1C precision monitoring needs of a wide range of test methods. The product is available in standard; glass vial; and barcoded, compact glass vial configurations to support diabetes testing workflows across major HbA1c analyzers.
In addition, the control includes a three-year shelf life and features 45-day open-vial stability for the standard vial and 30-day open-vial stability for the compact vial—eliminating the use of multiple vials for daily quality control.
For more information, visit Bio-Rad Laboratories.
Featured Image: Bio-Rad Laboratories’ Liquichek Diabetes Control comes in three distinct levels to address the HbA1C precision monitoring needs of a wide range of test methods. Photo: Bio-Rad Laboratories
